Development of a microsimulation of melanoma mortality for evaluating the effectiveness of population-based skin cancer screening

Medical Decision Making

Volumn 35, Issue 2, 2015, Pages 243-254

  Eisemann, Nora ^a   Waldmann, Annika ^a   Garbe, Claus ^b   Katalinic, Alexander ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Germany; melanoma; microsimulation; mortality; skin cancer screening

Indexed keywords

ADULT; AGED; BIOMETRY; COMPUTER SIMULATION; EARLY DIAGNOSIS; FEMALE; GERMANY; HUMAN; MALE; MELANOMA; MIDDLE AGED; MORTALITY; PATHOLOGY; PROCEDURES; REGISTER; RISK ASSESSMENT; SKIN NEOPLASMS; STATISTICS AND NUMERICAL DATA; SURVIVAL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMETRY; COMPUTER SIMULATION; EARLY DETECTION OF CANCER; FEMALE; GERMANY; HUMANS; MALE; MELANOMA; MIDDLE AGED; REGISTRIES; RISK ASSESSMENT; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 84921421222     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X14543106     Document Type: Article

References (38)

1. 2007 /2008. Incidence and Trends. 8th ed.Berlin, Germany: Robert Koch Institute and the Association of Population-Based Cancer Registries in Germany; 2012. Berlin, Germany: Robert Koch Institute and the Association of Population-Based Cancer Registries in Germany ; 2012:
2. Cristofolini M, Bianchi R, Boi S, et al. Effectiveness of the health campaign for the early diagnosis of cutaneous melanoma in Trentino, Italy. J Dermatol Surg Oncol. 1993 ; 19 (2). 117-20
3. De Rooij MJ, Rampen FH, Schouten LJ, Neumann HA. Total skin examination during screening for malignant melanoma does not increase the detection rate. Br J Dermatol. 1996 ; 135 (1). 42-5
4. Rossi CR, Vecchiato A, Bezze G, et al. Early detection of melanoma: an educational campaign in Padova, Italy. Melanoma Res. 2000 ; 10 (2). 181-7
5. Schneider JS, Moore DH, Mendelsohn ML. Screening program reduced melanoma mortality at the Lawrence Livermore National Laboratory, 1984 to 1996. J Am Acad Dermatol. 2008 ; 58 (5). 741-9
6. Stratigos A, Nikolaou V, Kedicoglou S, et al. Melanoma/skin cancer screening in a Mediterranean country: results of the Euromelanoma Screening Day Campaign in Greece. J Eur Acad Dermatol Venereol. 2007 ; 21 (1). 56-62
7. Eisemann N, Jansen L, Holleczek B, et al. Up-to-date results on survival of patients with melanoma in Germany. Br J Dermatol. 2012 ; 167 (3). 606-12
8. 6 th edition.Berlin, Heidelberg, New York: Springer; 2002. Wittekind C Meyer H-J Bootz F, ed. Berlin, Heidelberg, New York: Springer ; 2002:
9. Geller AC, Zhang Z, Sober AJ, et al. The first 15 years of the American Academy of Dermatology skin cancer screening programs: 1985-1999. J Am Acad Dermatol. 2003 ; 48 (1). 34-41
10. Geller AC, Sober AJ, Zhang Z, et al. Strategies for improving melanoma education and screening for men age >or= 50 years: findings from the American Academy of Dermatological National Skin Cancer Screening Program. Cancer. 2002 ; 95 (7). 1554-61
11. Lowe JB, Ball J, Lynch BM, et al. Acceptability and feasibility of a community-based screening programme for melanoma in Australia. Health Promot Int. 2004 ; 19 (4). 437-44
12. Aitken JF, Elwood JM, Lowe JB, Firman DW, Balanda KP, Ring IT. A randomised trial of population screening for melanoma. J Med Screen. 2002 ; 9 (1). 33-7
13. Breitbart EW, Waldmann A, Nolte S, et al. Systematic skin cancer screening in Northern Germany. J Am Acad Dermatol. 2012 ; 66 (2). 201-11
14. Katalinic A, Waldmann A, Weinstock MA, et al. Does skin cancer screening save lives? An observational study comparing trends in melanoma mortality in regions with and without screening. Cancer. 2012 ; 118 (21). 5395-402
15. Wolff T, Tai E, Miller T Maryland: Agency for Healthcare Research and Quality ; 2009:
16. Whiteman D. Melanoma screening: the Australian perspective. Melanoma Res. 2010 ; 20: e1 - e91
17. Karnon J, Goyder E, Tappenden P, et al. A review and critique of modelling in prioritising and designing screening programmes. Health Technol Assess. 2007 ; 11 (52). iii ix 1 - iv xi 145
18. Rutter CM, Zaslavsky AM, Feuer EJ. Dynamic microsimulation models for health outcomes: a review. Med Decis Making. 2011 ; 31 (1). 10-8
19. Carlson JA. Tumor doubling time of cutaneous melanoma and its metastasis. Am J Dermatopathol. 2003 ; 25 (4). 291-9
20. Hiripi E, Gondos A, Emrich K, et al. Survival from common and rare cancers in Germany in the early 21st century. Ann Oncol. 2012 ; 23 (2). 472-9
21. Eisemann N, Waldmann A, Katalinic A. Imputation of missing values of tumour stage in population-based cancer registration. BMC Med Res Methodol. 2011 ; 11: 129
22. Association of Population-Based Cancer Registries in Germany (GEKID). Map of cancer incidence and mortality in Germany (GEKID atlas). Available from: URL: http://www.gekid.de.
23. Waldmann A, Nolte S, Weinstock MA, et al. Skin cancer screening participation and impact on melanoma incidence in Germany - an observational study on incidence trends in regions with and without population-based screening. Br J Cancer. 2012 ; 106 (5). 970-4
24. Rampen FH, Casparie-van Velsen JI, van Huystee BE, Kiemeney LA, Schouten LJ. False-negative findings in skin cancer and melanoma screening. J Am Acad Dermatol. 1995 ; 33 (1). 59-63
25. Hautkrebsscreening - Zusammenfassende Dokumentation des Unterausschusses Prävention des Gemeinsamen Bundesausschusses. Siegburg (Germany): Gemeinsamer Bundesausschuss. 2008 ;:
26. Girgis A, Clarke P, Burton RC, Sanson-Fisher RW. Screening for melanoma by primary health care physicians: a cost-effectiveness analysis. J Med Screen. 1996 ; 3 (1). 47-53
27. Freedberg KA, Geller AC, Miller DR, Lew RA, Koh HK. Screening for malignant melanoma: a cost-effectiveness analysis. J Am Acad Dermatol. 1999 ; 41 (5). 738-45
28. Beddingfield FC Santa Monica (CA): RAND Graduate School ; 2002:
29. Koh HK, Norton LA, Geller AC, et al. Evaluation of the American Academy of Dermatology's National Skin Cancer Early Detection and Screening Program. J Am Acad Dermatol. 1996 ; 34 (6). 971-8
30. Schmid-Wendtner MH, Baumert J, Stange J, Volkenandt M. Delay in the diagnosis of cutaneous melanoma: an analysis of 233 patients. Melanoma Res. 2002 ; 12 (4). 389-94
31. Erdmann F, Lortet-Tieulent J, Schuz J, et al. International trends in the incidence of malignant melanoma 1953-2008 - are recent generations at higher or lower risk?. Int J Cancer. 2013 ; 132 (2). 385-400
32. Levell NJ, Beattie CC, Shuster S, Greenberg DC. Melanoma epidemic: a midsummer night's dream?. Br J Dermatol. 2009 ; 161 (3). 630-4
33. Paap E, Verbeek AL, Puliti D, Paci E, Broeders MJ. Breast cancer screening case-control study design: impact on breast cancer mortality. Ann Oncol. 2011 ; 22 (4). 863-9
34. Otto SJ, Fracheboud J, Verbeek AL, et al. Mammography screening and risk of breast cancer death: a population-based case-control study. Cancer Epidemiol Biomarkers Prev. 2012 ; 21 (1). 66-73
35. Paci E, Duffy SW, Giorgi D, et al. Quantification of the effect of mammographic screening on fatal breast cancers: The Florence Programme 1990-96. Br J Cancer. 2002 ; 87 (1). 65-9
36. Olsen AH, Njor SH, Lynge E. Estimating the benefits of mammography screening: the impact of study design. Epidemiology. 2007 ; 18 (4). 487-92
37. Puliti D, Zappa M. Breast cancer screening: are we seeing the benefit?. BMC Med. 2012 ; 10: 106
38. Bretthauer M. Colorectal cancer screening. J Intern Med. 2011 ; 270 (2). 87-98